| Mrs Dawn Michelle Taylor Gizzio, | |
|
2205 Philadelphia Pike, Claymont, DE 19703-2428 | |
| (302) 893-4945 | |
| Not Available |
| Full Name | Mrs Dawn Michelle Taylor Gizzio |
|---|---|
| Gender | Female |
| Speciality | Counselor - Professional |
| Location | 2205 Philadelphia Pike, Claymont, Delaware |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1881129104 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YP2500X | Counselor - Professional | PC-0000801 (Delaware) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Dawn Michelle Taylor Gizzio, 5151 Chichester Ave, Upper Chichester, PA 19014-2313 Ph: (610) 485-5335 | Mrs Dawn Michelle Taylor Gizzio, 2205 Philadelphia Pike, Claymont, DE 19703-2428 Ph: (302) 893-4945 |
News Archive
A new study published on the preprint server bioRxiv reports the elucidation of the mechanism of inhibition of SARS-CoV-2 by a non-nucleotide inhibitor called suramin. This is the first such compound to be shown to have such activity and shows promise for use as a repurposed drug against COVID-19.
EpiCept Corporation today announced that a Nasdaq Hearings Panel has granted the Company's request for continued listing on The Nasdaq Stock Market.
Sun Biomedical Limited today announced the first patient had been enrolled in a Phase II study of DMX-200, an innovative new treatment that combines two different drugs to treat chronic kidney disease.
The Lancet, the world's leading independent general medical journal, today announced its first app for iPad is now available on the App Store. The Lancet App is an innovative article-based navigation app that makes it easier for healthcare professionals (HCPs) to find the information they need quickly and efficiently from the convenience of their iPad.
Quark Pharmaceuticals, Inc., a world leader in the discovery and development of RNAi-based therapeutics, today announced results from a second study of QPI-1007, a neuroprotective siRNA drug, in rat ocular hypertension model of glaucoma, conducted by Prof. Adriana Di Polo of the Department of Pathology and Cell Biology, Universite de Montreal.
› Verified 3 days ago
Earl Carter, Counselor Medicare: Not Enrolled in Medicare Practice Location: 98 Harvey Rd, Claymont, DE 19703 Phone: 302-375-0354 Fax: 302-375-0359 | |
Aaron Prince, Counselor Medicare: Not Enrolled in Medicare Practice Location: 98 Harvey Rd, Claymont, DE 19703 Phone: 302-375-0354 Fax: 302-375-0359 | |
Jennifer Jerez, LPCMH Counselor Medicare: Not Enrolled in Medicare Practice Location: 650 Naamans Rd Ste 110, Claymont, DE 19703 Phone: 302-224-1400 | |
Tracie Beltran, Counselor Medicare: Not Enrolled in Medicare Practice Location: 590 Naamans Rd, Claymont, DE 19703 Phone: 302-442-6194 Fax: 302-442-6940 | |
Ms. Nicole R. Moore, MSW, CADC Counselor Medicare: Not Enrolled in Medicare Practice Location: 2999 Philadelphia Pike, Claymont, DE 19703 Phone: 302-792-0700 Fax: 302-798-2608 | |
Maria I Cruz, Counselor Medicare: Not Enrolled in Medicare Practice Location: 98 Harvey Rd, Claymont, DE 19703 Phone: 302-375-0354 Fax: 302-375-0359 | |
Tanya Johnson, MA Counselor Medicare: Not Enrolled in Medicare Practice Location: 3301 Green St, Claymont, DE 19703 Phone: 302-439-4951 |